4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-016044
Options or other derivatives
- EVP, R&D & CMO acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · EVP, R&D & CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-04 | Grant or award : show line 1 in the form Stock option (right to buy) | +55,000 | $145.48 | 2029-03-04 | 55,000 | 55,000 | D |
Loading xslF345X03/doc4.xml…